The "nice and pretty" published version of our Perspective discussing the ACTUAL evidence of naloxone's "enabling" consequences (which there is very little) and the research examining the PERCEPTION that naloxone is "enabling" is out now, if you haven't read it yet!

doi.org/10.15288/jsa...

Oh my gosh congratulations!! 🥳🎉 You should definitely be feeling proud and excited!!

Just 7 days until the panel discussing lived perspectives on the opioid vaccine! 💉 Hope to see you there in-person or on Zoom!

The Drug war was built for control, not care. Now history is repeating itself. 🧵

(Thank you to the amazing Morgan B. at the UMSL-MIMH Addiction Science Team for helping draft this post!)

Authored by @rayraywino.bsky.social & myself, this piece challenges how we frame harm reduction. A must-read for anyone working in addiction science, policy, or public health.

Read the pre-proof here: bsky.app/profile/jsad...

Framing matters. How we talk about moral hazard vs. risk compensation shapes the evaluation of safety net strategies like naloxone. Let’s focus on evidence, not stigma.

In our new Perspective in the Journal of Studies on Alcohol and Drugs @jsadjournal.bsky.social we dive into how critiques of naloxone often confuse moral hazard (population-level) with risk compensation (individual-level). Two different concepts that can (and should) be tested with real-world data.

What do naloxone, PrEP, helmets & seatbelts share? They’re tools that reduce harm, as a safety net that only “activates” when risk is present. Yet naloxone gets uniquely branded as “enabling.” WHY? And why does it MATTER?

What an insult to our harm reduction movement and elders who fought so hard for naloxone and fentanyl test strip access.

Check out the atrocious language in the latest letter from SAMHSA claiming these tools are "not harm reduction."

www.samhsa.gov/sites/defaul...

IMPORTANT UPDATE IMPORTANT UPDATE

Regarding APHU/ACLU et al. vs. NIH Lawsuit

This panel is scheduled for Friday, Aug. 29th, 12:00pm-1:00pm Central Time, and will be hosted in-person (in Benton Hall on UMSL campus) and on Zoom (please refer to the QR code in the banner).
Questions or comments? Email me (or DM me on Bluesky), since I'm moderating the panel!

Have you heard about the novel opioid vaccine / fentanyl vaccine?
If not (or even if you have!), our next SURG Brunch 'n Learn meeting will feature our first-ever Translational Panel - composed of four people with lived experience in drug use - discussing the novel opioid vaccine in development.

If I hear one more reporter say these attacks on universities and science are about "antisemitism," I am going to lose it. This is about destroying higher education full stop and it doesn't help to parrot the White House's talking points. www.science.org/content/arti...

The truth? Medicaid (largest payer of addiction treatment) faces $800B in cuts. SAMSHA's been cut by $1B and lost 1/3 of its staff. This all threatens access to treatment, fentanyl withdrawal meds & naloxone. In NC, Project Lazarus lost DOJ grants for jail-to-treatment diversion.

In no particular order, thank you for saying hi, as it made my day each day! Cecilia Bergeria, Denis Antoine, Justin Strickland, Kelly Dunn, Matt Novak, Jennifer Ellis, Eric Strain, Andrew Huhn, Caitlin Durgin, Kevin Xu - and new connections Tanya Saraiya, Elizabeth Salisbury-Afshar, Phillip Coffin!

I appreciate @kaytryncampbell.bsky.social for keeping me company all the time and @cpddorg.bsky.social for coordinating mentor-match so I could meet Delisa Brown (to whom I am also grateful)! Also, I remember being so kindly welcomed as a First-Time Attendee by CPDD Board Member Qiana Brown! 🥰

I'm still in awe after attending and presenting at #CPDD2025, which marks a big personal and professional milestone to see all my mentors and senior scholars in action! Alongside them, I'm proud to have garnered plenty foot traffic at my poster on MOUD stigma among residents in recovery housing!

While the Trump administration was having a birthday party, we were marching across the nation for our rights.

And we’re not slowing down.

Science is under unprecedented threat in the US, and we need to speak out to save it.

If you are an early-career researcher, please consider signing our open letter calling to preserve the future of American science: tinyurl.com/mcclintockle....

Our futures, and our country's future, depend on it.

Super grateful to my co-authors who reviewed my analyses and contributed to writing on this fun "summer project" (... it's June again, right? 🫢), and to the ART Production Team for their patience as this was my first time being responsible for submitting and proofing a manuscript! 😅

Applying the Dualistic Model of Passion to opioid use with a treatment-seeking clinical sample? Interestingly, observed higher 'obsessive passion' mean than 'harmonious passion' mean, which contrasts past DMP + substance use studies but aligns with one DMP + gambling study!

doi.org/10.1080/1606...

Please excuse my bedhead 😴 - feeling proud to have presented at my first #CPA2025, examining differential stigma toward MOUD among recovery housing residents based on their own lived experience with these meds! Thank you to mentors, co-authors, and friends for their support with this project!

Thanks to mentors, co-authors, and friends for their support and presence throughout this project. 💜
And look out for the upcoming papers from this MO I-STARR grant!